TD Cowen Maintains Buy on BrightSpring Health, Raises Price Target to $84

Benzinga · 1d ago
TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.